Orexins-A and -B are hypothalamic peptides derived from a precursor called prepro-orexin and relationated with the stimulation of food intake. They act on G protein receptors named orexin receptor 1 (OX 1 R) and orexin receptor 2 (OX 2 R), respectively. In the present study, we used RT-PCR and immunohistochemical techniques to detect the presence of OX 1 R and OX 2 R in human pituitary. A band of the expected size for both OX 1 R and OX 2 R was shown in human pituitary by RT-PCR. The cellular localization of OX 1 R and OX 2 R was carried out using histological techniques. By consecutive sections we demonstrated that OX 1 R was present in acidophil, diffusely distributed cells, which represent the half of the total adenohypophysis cell population. As was expected, these cells were shown to coexpress GH. OX 2 R was found in the pars intermedia and in clusters of basophil cells of the anterior pituitary, which coexpress ACTH. These results were confirmed by double immunofluorescence techniques. We also found focal positivity in axon terminals of neurohypophysis, more intense for OX 2 R than for OX 1 R. In conclusion, these results demonstrated for the first time that OX 1 R and OX 2 R were expressed by somatotrope and corticotrope cells, respectively. (J Clin Endocrinol Metab 86: 1616 -1619, 2001) O REXINS ARE HYPOTHALAMIC peptides that arise by proteolysis from a 130 amino acid common precursor (prepro-orexin) that is mainly synthesized in neurons within and around the lateral and posterior hypothalamus (1, 2). The orexin-containing neurons project to multiple neuronal systems (3). Orexin-A and -B are 33 and 28 residue peptides, respectively, that show a 46% sequence homology and are very similar in rats and humans (orexin-A is identical in both species, and orexin-B only differs in 2 residues). Orexins act on G protein previously orphan receptors named orexin receptor 1 (OX 1 R) and orexin receptor 2 (OX 2 R). OX 1 R is selective for orexin-A, whereas OX 2 R binds both orexin-A and -B (2). Orexin receptors have a broad distribution in the brain (4). Orexins, after the Greek word "orexis," which means appetite, have a physiological role in the stimulation of food intake (2). The wide distribution of orexin fibers and orexin receptors indicate that orexins may play important physiological roles other than feeding, such as modulation of macrophage functions (5); regulation of blood pressure, neuroendocrine system, body temperature, and sleep-waking cycle (3, 6 -8); stimulation of gastric acid secretion (9); and involvement in the stress reaction in rats (10). Recently, hybridization signals for orexin receptors were demonstrated in rat pituitary (primarily in the intermediate and anterior lobes; Ref. 11). To define a possible direct regulatory role of orexins on pituitary cell function, we have sought to characterize the expression of both orexin receptors in the human adenohypophysis as well as to identify the cell types that express these proteins. To this end, we used a combination of different techniques such as RT-PCR and immunohistochemistry.
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Materials and Methods Tissues
Human pituitaries from seven individuals [four males and three females; mean age, 64.7 yr (range, 46 -85)] were obtained from recent autopsies (Ͻ24 h) performed at the Pathology Department (Prof. J. Forteza) of the University Clinical Hospital (Santiago de Compostela, Spain). None of the patients had evidence or history of endocrine disease.
RNA isolation
Pituitary (adenohypophysis and posterior lobe) and hypothalamic samples were frozen immediately in dried ice. Total RNA was isolated using Trizol Reagent (Life Technologies, Inc., Rockville, MD). For RNA integrity analysis, 5 g total RNA were resolved in a 1% agarose gel and the RNA was visualized by ethidium bromide fluorescence in a digital imaging system (Molecular Analyst; Bio-Rad Laboratories, Inc., Richmond, CA). Pituitary RNA shows a good preservation state (Fig. 1A) .
RT-PCR
The RT reaction was carried out in a volume of 30 L containing 3 g total RNA and incubated at 37 C for 60 min. The enzyme was inactivated by heating at 95 C for 5 min.
We amplified 9 L of the RT product. We have designed the following sets of primers: OX 1 R, 5Ј-TGAAGTGAAGCAGATGCGTGC-3Ј and 5Ј-TGGTGACGCTGGTGAGCA-3Ј (the size of the product is 412 bp); OX 2 R, 5Ј-AGCAGATCCGAGCCAGAAGG-3Ј and 5Ј-GGCTGCTGG-GAGTGTGCTTA-3 (the size of the product is 425 bp).
The temperatures and times used were 38 cycles at 94 C for 1 min, 67 C for 1 min, 72 C for 1 min, with a final extension step at 72 C for 10 min.
We used hypoxanthine-guanine phosphoribosyltransferase as a housekeeping gene, amplified as described above using the following primers: 5Ј-CAGCCCTGGCGTCGTGATTA-3Ј and 5Ј-GCAAGACGT-TCAGTCCTGTC-3Ј (the size of the PCR product is 138 bp).
Amplifications were carried out in a DNA thermal cycler (Eppendorf, Hamburg, Germany). Each RNA sample was retrotranscribed and amplified simultaneously with a retrotranscriptase-free control to discard possible contamination with DNA. The amplified products were resolved in a 2% agarose gel, and the DNA was visualized by ethidium bromide fluorescence in a digital imaging system (Molecular Analyst; Bio-Rad Laboratories, Inc.).
Immunohistochemistry
The pituitary samples were immediately immersion fixed in 10% buffered formalin for 24 h, dehydrated, and embedded in paraffin by a standard procedure. Serial sections 4 m thick were mounted on 3-aminopropyltriethoxysilane-coated slides and deparaffinized before hematoxylin and eosin staining or immunohistochemical techniques. Rabbit polyclonal antisera anti-OX 1 R and anti-OX 2 R (Alpha Diagnostic, San Antonio, TX) were used. Both antisera have been previously validated for immunohistochemistry (12) . Antigen retrieval was carried out by pressure cooker unmasking for 2 min in 0.01 m sodium citrate buffer (pH 6.0). Polyclonal antisera anti-GH (Dakopatts, Glostrup, Denmark) and anti-ACTH (BioGenex Laboratories, Inc. San Ramon, CA) were also used without unmasking procedure. The streptavidin-biotin complex immunohistochemical method was used, and the sections were consecutively incubated in: 1) polyclonal antibodies anti-OX 1 R at a dilution of 1:200 for 1 h, anti-OX 2 R at 1:100 overnight, anti-GH at 1:2000 for 1 h, or anti-ACTH at 1:100 for 1 h; 2) 3% hydrogen peroxide for 10 min (Merck, Darmstadt, Germany) to block endogenous peroxidase; 3) biotinylated goat antibodies to mouse/rabbit immunoglobulins (Duet kit; Dakopatts) at a dilution of 1:100 for 30 min; 4) streptavidin-biotin-peroxidase complex (Duet kit; Dakopatts), prepared according to the protocol provided by the manufacturer, for 30 min; and 5) 3,3Ј-diamino-benzidine-tetrahydrochloride solution prepared by dissolving one 3,3Ј-diamino-benzidine-tetrahydrochloride-buffer tablet (Merck) in 10 mL distilled water for 10 min. Between steps, the sections were washed twice for 5 min with PBS [0.01 mol/L phosphate buffer (pH 7.4) containing 0.15 mol/L NaCl] and, after step 5, with distilled water. All dilutions were made in PBS. This buffer was added with 0.1% BSA (Sigma, St. Louis, MO) for dilution of the primary antisera (step 1) and with 1.5% normal goat serum (Dakopatts) for the biotinylated antibodies (step 3). No counterstaining was done.
Controls for specificity of immunohistochemistry included incubation with the primary antibodies preabsorbed overnight at 4 C with the immunogen peptides (OX 1 R and OX 2 R, 10 nmol/mL; Alpha Diagnostic) and using alternately PBS in place of one of the other incubation steps.
Double labeling
Double labeling experiments were carried out on paraffin sections processed as described. Primary antibodies against OX 1 R (rabbit polyclonal diluted at 1:25; Alpha Diagnostic) and GH (mouse monoclonal diluted at 1:200; Chemicon International, Temecula, CA) were mixed and applied to the slides and incubated overnight. After two washes in PBS, incubation with specie-specific secondary antibody was done: goat antirabbit coupled with tetramethylrhodamine isothiocyanate (Sigma, St. Louis, MO) diluted at 1:25 and goat antimouse coupled with fluorescein isothiocyanate (FICT; Sigma) diluted at 1:40 in PBS with 10% of normal goat serum (Dakopatts). Antirabbit OX 2 R (Alpha Diagnostic) was labeled with Cy3 Fluor Kit (Amershan Pharmacia, Little Chalfont, BuckingHamshire, UK), and antihuman ACTH obtained from the National Institute of Diabetes, Digestive and Kidney Diseases was labeled with FICT Fluor Kit (Amershan Pharmacia). Fifty microliters of each antibody were applied to the slides and incubated overnight individually. After washing in distilled water, slides were mounted with Immuno-Fluore mounting medium (ICN, Aurora, Ohio). The sections were observed and photographed by using a Provis AX70 microscope (Olympus Corp., Tokyo, Japan).
Results

RT-PCR
RT-PCR of human adenohypophysis complementary DNA yielded a band of the expected size for both OX 1 R and OX 2 R (Fig. 1B) .
Immunohistochemistry
Intense immunoreactivity for orexin receptors was demonstrated in the human adenohypophysis. By serial sections, immunoreactivity for OX 1 R was demonstrated in acidophil cells (Fig. 2, A and B) , whereas positivity for OX 2 R was found in basophil cells (Fig. 2, C and D) . The OX 1 R immunostaining was more intense than that of OX 2 R. OX 1 R expression was found in ϳ50% of all adenohypophysal cells that were diffusely distributed. The staining properties (acidophilia), percentage, and distribution of the cells led us to identify them as somatotropes, a fact that was demonstrated by immuno- (Fig. 2, E  and F) . Positivity for OX 2 R was very intense in the pars intermedia (Fig. 2, C and D) and in focal clusters of basophil cells of the anterior pituitary (Fig. 2G) . As expected for these characteristics, OX 2 R-positive cells were shown to coexpress ACTH (Fig. 2, G and H) . At high magnification, immunostaining was also found in scarce axon terminals of the neurohypophysis, and in this localization the signal intensity was more markedly for OX 2 R (Fig. 2I ) than for OX 1 R (data not shown). No immunostaining was observed either when any essential step of the reaction was omitted, or when the primary antisera were preabsorbed with their homologous antigens (Fig. 2, J and K) .
Double labeling
To confirm the previous results, double immunofluorescence techniques were used. Two-color immunofluorescence demonstrated that all OX 1 R-positive cells were also GH positive (Fig. 2, L-N) and that all OX 2 R-positive cells were also ACTH positive (Fig. 2 , O-Q).
Discussion
Orexins are synthesized in neurons of the lateral and posterior hypothalamus and have a central role in feeding regulation. However, the demonstration of a wide projection of orexin nerve fibers in the brain suggest complex roles of the peptides in autonomic and neuroendocrine control (3, 7) , and the broad central distribution of orexin receptors may indicate additional as yet undefined physiological functions for orexins (4) .
The present study describes for the first time the expression of orexin receptors in human pituitary. Recently, orexin receptor messenger RNAs were demonstrated in rat pituitary by in situ hybridization techniques. Intense signals were shown in the intermediate and anterior lobes, and weak signals in the posterior lobe (11) . These authors also demonstrated that in the rat anterior lobe the expression of OX 1 R was more intense than that of OX 2 R. These results are in agreement with our findings in human pituitary where the cells immunostained for OX 1 R were much more numerous than the cells expressing OX 2 R. Immunohistochemistry performed in serial sections and double immunofluorescence techniques allowed us to demonstrate that all OX 1 R-expressing cells were somatotropes and that all OX 2 Rexpressing cells were corticotropes. To confirm the previous results, double immunofluorescence techniques were used. As in the study by Date et al. (11) , we also found a weak expression of orexin receptors in the neurohypophysis. However, these authors showed that the signal intensity of OX 1 R messenger RNA in the intermediate lobe of the rat was as strong as that of OX 2 R (11), and in human pituitary we found that basophil cells characteristic of the pars intermedia only express OX 2 R. Recently, it was demonstrated that the plasma concentrations of ACTH and corticosterone were significantly increased after central administration (13) or sc injection (14) of orexin-A. On the other hand, central administration of orexin-A seems to inhibit in vivo GH secretion in the rat (our unpublished observations). Although it has been proposed that these effects may result from the release of hypothalamic factors (13) , our data open up the possibility that some of the neuroendocrine actions of these peptides could be exerted directly at pituitary level. In summary, the present findings provide the first evidence that orexin receptors are expressed in the human pituitary gland. Whereas somatotrope cells seem to express OX 1 R, positive immunostaining for OX 2 R was found in corticotropes. It remains to be established whether alteration in orexin receptors gene expression could lead to alterations in human pituitary cell proliferation and/or hormone secretion.
